Russian Medical Academy of Continuous Professional Education, Moscow.
Servier JSC, Moscow.
Kardiologiia. 2022 Jan 31;62(1):89-97. doi: 10.18087/cardio.2022.1.n1862.
Most patients with arterial hypertension (AH) require a combination treatment to achieve the goal blood pressure. According to Russian and international clinical guidelines on the treatment of AH patients, various antihypertensive drugs may be combined; however, not all combinations have similar profiles of safety and clinical efficacy. In this respect, special attention is given to combinations of renin-angiotensin-aldosterone system inhibitors and thiazide (hydrochlorothiazide) or thiazide-like (chlortalidone, indapamide) diuretics. Diuretics also differ in their mechanisms of action, presence of pleiotropic effects and organ-protective properties, effects on the prognosis, and in the evidence base. This review discusses the place of thiazide and thiazide-like diuretics in the treatment of patients with AH and provides an evaluation of major differences in pharmacological and clinical effects of drugs of the diuretic class.
大多数高血压(AH)患者需要联合治疗才能达到目标血压。根据俄罗斯和国际 AH 患者治疗临床指南,可能会联合使用各种降压药物;然而,并非所有联合治疗都具有相似的安全性和临床疗效特征。在这方面,特别关注肾素-血管紧张素-醛固酮系统抑制剂与噻嗪类(氢氯噻嗪)或噻嗪样(氯噻酮、吲达帕胺)利尿剂的联合治疗。利尿剂的作用机制、存在的多效性和器官保护特性、对预后的影响以及证据基础也存在差异。这篇综述讨论了噻嗪类和噻嗪样利尿剂在 AH 患者治疗中的地位,并评估了利尿剂类药物在药理学和临床效果方面的主要差异。